340 related articles for article (PubMed ID: 19864973)
1. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients.
Demir M; Gokturk HS; Ozturk NA; Arslan H; Serin E; Yilmaz U
South Med J; 2009 Nov; 102(11):1116-20. PubMed ID: 19864973
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistant strains.
Mahachai V; Thong-Ngam D; Noophun P; Tumwasorn S; Kullavanijaya P
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S74-8. PubMed ID: 17718272
[TBL] [Abstract][Full Text] [Related]
4. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
[TBL] [Abstract][Full Text] [Related]
6. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
7. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
[TBL] [Abstract][Full Text] [Related]
8. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
Lee HJ; Kim JI; Cheung DY; Kim TH; Jun EJ; Oh JH; Chung WC; Kim BW; Kim SS; Park SH; Kim JK
J Infect Dis; 2013 Oct; 208(7):1123-30. PubMed ID: 23801607
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
12. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
Demir M; Göktürk S; Oztürk NA; Serin E; Yilmaz U
Digestion; 2010; 82(1):47-53. PubMed ID: 20410684
[TBL] [Abstract][Full Text] [Related]
13. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study.
Demir M; Gokturk HS; Ozturk NA; Serin E; Yilmaz U
Am J Med Sci; 2009 Dec; 338(6):459-64. PubMed ID: 19884816
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
17. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
18. Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.
Gu Q; Xia HH; Wang JD; Wong WM; Chan AO; Lai KC; Chan CK; Yuen MF; Fung FM; Wong KW; Lam SK; Wong BC
Digestion; 2006; 73(2-3):101-6. PubMed ID: 16788304
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance.
Erdur B; Ozturk Y; Gurbuz ED; Yilmaz O
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):530-3. PubMed ID: 22465935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]